Home
NICE Guidance
Published Guidance
Adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis
Technology appraisal guidance [TA130]
Published date:
22 October 2007
Guidance
This guidance has been updated and replaced by
NICE technology appraisal guidance 375
.